Evidence map›Paper›PMID 42846858›Full record

ArticleFrontiers in endocrinology2026

Case Report: Minipuberty hormonal profile in

Marie Voide, Federico Santoni, Lucia Bartoloni, Jenny Meylan-Merlini, Oliver Sanchez, Michael Hauschild, Nelly Pitteloud, Kanetee Busiah

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marie VoideFaculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Federico SantoniFaculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Lucia BartoloniService of Endocrinology, Diabetology, and Metabolism, Lausanne University Hospital, Lausanne, Switzerland.
Jenny Meylan-MerliniService of Endocrinology, Diabetology, and Metabolism, Lausanne University Hospital, Lausanne, Switzerland.
Oliver SanchezService of Pediatric Surgery, Department of Mother-Woman-Child, Lausanne University hospital, Lausanne, Switzerland.
Michael HauschildFaculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Nelly PitteloudFaculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Kanetee BusiahFaculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Persistent Müllerian duct syndrome (PMDS) is a rare difference/disorder of sex development and maturation characterized by the retention of Müllerian structures during fetal development in individuals with a 46,XY karyotype. It is typically due to mutations in anti-Müllerian hormone (

Indexed as

Disorder of Sex Development, 46,XYProtein Phosphatase 1Anti-Mullerian HormoneFrameshift MutationHumansHypothalamic-Pituitary-Gonadal AxisInfant, NewbornInhibinsMaleAnti-Mullerian HormoneInhibinsProtein Phosphatase 146,XY disorder of sex developmentde novo frameshift variantminipubertypersistent Müllerian duct syndromePPP1R12A-related urogenital and/or brain malformation syndrome

Identifiers

PMID42846858
PMCPMC13643745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.